Clinical Trial Update: Comparison of Buprenorphine/Naloxone With Naltrexone in Opioid Dependent Adolescents [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing buprenorphine/naloxone with naltrexone in opioid-dependent adolescents has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Use Disorder

Drugs mentioned

• Buprenorphine/naloxone (buprenorphine/naloxone)
• Naltrexone (Naltrexone)

Snippet

Sponsor: State University of New York at Buffalo | Conditions: Opiate Addiction | Phase 4 | Status: WITHDRAWN